Form 4: Celularity Executive Kyle Fletcher Reports Stock Transaction
SEC Form 4 Filing
Kyle Fletcher, Executive Vice President and General Counsel of Celularity Inc., reports the withholding of shares to cover tax obligations related to vested restricted stock units.
Summary
- On March 15, 2024, Kyle Fletcher, Executive Vice President and General Counsel of Celularity Inc., had 617 shares of Class A Common Stock withheld by the issuer to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
- The price per share for the transaction was $5.68.
- Following the transaction, Fletcher directly owns 21,105 shares, which includes 20,372 shares underlying RSUs granted under the Celularity Inc. 2021 Equity Incentive Plan.
- All share numbers have been adjusted to reflect a 1-for-10 reverse stock split that occurred on February 29, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders reporting transactions in their company's stock. It provides transparency into the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| February 29, 2024 | Celularity Inc. effected a 1-for-10 reverse stock split. |
| March 15, 2024 | Kyle Fletcher had shares withheld to satisfy tax obligations related to vested RSUs. |
| March 19, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.